Literature DB >> 8210966

Oxygen radicals stimulate thromboxane and prostacyclin synthesis and induce vasoconstriction in pig lungs.

J Sanderud1, K Bjøro, O D Saugstad.   

Abstract

Reactive oxygen species have earlier been shown to induce vasoactive changes. In the present investigation we hypothesized that active oxygen intermediates would stimulate arachidonic acid metabolism and thereby influence the pulmonary circulation. Four groups of 8-week old pigs were studied after infusion of an oxygen radical generator. Haemodynamic changes were recorded, and thromboxane (TX)B2 (the stable metabolite of TXA2) and 6-keto-prostaglandin (PG)F1 alpha (the stable metabolite of prostacyclin, PGI2) measured by a radioimmunoassay technique after infusion of xanthine oxidase (XO) alone or in combination with pharmacological inhibitors. In the XO group pulmonary vascular resistance increased rapidly compared to baseline levels. Maximum resistance increase was 118.4 +/- 27.5%, 25 min after the XO infusion (p < 0.05 compared to baseline). The vasoconstriction was significantly attenuated after pretreatment with the cyclo-oxygenase inhibitor indomethacin. In this group the pulmonary resistance increase was 21.2 +/- 24.3% at 25 min (p < 0.01 vs. XO group). In a group given allopurinol (xanthine oxidase inhibitor), the resistance increased by 44.3 +/- 28.8% (p < 0.02 vs. XO group), and during catalase infusion (hydrogen peroxide scavenger), the increase was 52.9 +/- 24.2% (p < 0.01 vs. XO group). Along with the pulmonary vascular pressure augmentation, we measured 1.9 fold TXB2 and 2.2 fold 6-keto-PGF1 alpha concentration increases in the XO group. However, both TXB2 and 6-keto-PGF1 alpha formation was significantly inhibited by indomethacin (p < 0.01 respectively vs. XO group), allopurinol (p < 0.01 and p < 0.05 respectively vs. XO group) and catalase (p < 0.01 and p < 0.02 respectively vs. XO group).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8210966     DOI: 10.1080/00365519309092539

Source DB:  PubMed          Journal:  Scand J Clin Lab Invest        ISSN: 0036-5513            Impact factor:   1.713


  8 in total

1.  Pulmonary arterial responses to reactive oxygen species are altered in newborn piglets with chronic hypoxia-induced pulmonary hypertension.

Authors:  Candice D Fike; Judy L Aschner; James C Slaughter; Mark R Kaplowitz; Yongmei Zhang; Sandra L Pfister
Journal:  Pediatr Res       Date:  2011-08       Impact factor: 3.756

Review 2.  Oxidative stress and peripartum outcomes (Review).

Authors:  Zsuzsanna Simon-Szabo; Erzsebet Fogarasi; Eniko Nemes-Nagy; Lorand Denes; Mircea Croitoru; Bela Szabo
Journal:  Exp Ther Med       Date:  2021-05-17       Impact factor: 2.447

3.  Effect of arachidonic and eicosapentaenoic acids on acute lung injury induced by hypochlorous acid.

Authors:  H Wahn; N Rüenauver; S Hammerschmidt
Journal:  Thorax       Date:  2002-12       Impact factor: 9.139

4.  Stimulation of pulmonary rapidly adapting receptors by inhaled wood smoke in rats.

Authors:  C J Lai; Y R Kou
Journal:  J Physiol       Date:  1998-04-15       Impact factor: 5.182

5.  Oxygen concentration and pulmonary hemodynamics in newborn lambs with pulmonary hypertension.

Authors:  Satyan Lakshminrusimha; Daniel D Swartz; Sylvia F Gugino; Chang-Xing Ma; Karen A Wynn; Rita M Ryan; James A Russell; Robin H Steinhorn
Journal:  Pediatr Res       Date:  2009-11       Impact factor: 3.756

Review 6.  Considerations in the management of hypoxemic respiratory failure and persistent pulmonary hypertension in term and late preterm neonates.

Authors:  S Lakshminrusimha; G G Konduri; R H Steinhorn
Journal:  J Perinatol       Date:  2016-06       Impact factor: 2.521

7.  The contribution of the immune system to parturition.

Authors:  R D Jongh; P Jorens; I Student; R Heylen
Journal:  Mediators Inflamm       Date:  1996       Impact factor: 4.711

Review 8.  Protective role of melatonin in neonatal diseases.

Authors:  Eloisa Gitto; Lucia Marseglia; Sara Manti; Gabriella D'Angelo; Ignazio Barberi; Carmelo Salpietro; Russel J Reiter
Journal:  Oxid Med Cell Longev       Date:  2013-11-19       Impact factor: 6.543

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.